Effectiveness of Nimesulide in Acute Fever Management in Adults: Retrospective Electronic Medical Records Database Study Outcome in Outpatient Department.


Journal

The Journal of the Association of Physicians of India
ISSN: 0004-5772
Titre abrégé: J Assoc Physicians India
Pays: India
ID NLM: 7505585

Informations de publication

Date de publication:
Jul 2021
Historique:
entrez: 25 8 2021
pubmed: 26 8 2021
medline: 27 8 2021
Statut: ppublish

Résumé

Various clinical trials have established anti-inflammatory and antipyretic properties of Nimesulide in a controlled setting, however, the fever management in real-world settings is quite different. To assess the effectiveness of Nimesulide in acute fever management in real-world clinical practice. A retrospective, multicenter study was conducted on electronic medical records (EMR) of 302 patients visiting out-patient departments at three centers between Jan 2016 and Jan 2020 and were prescribed Nimesulide for acute fever. The effectiveness of Nimesulide was analyzed as a change in fever from baseline to follow-up visit within 14 days and tolerability as the number of side effects captured post-Nimesulide ingestion. The provisional diagnosis at the baseline visit reported major complaints like fever, fever with abdominal pain, body-ache, cough and myalgia. The mean baseline body temperature was 103.2±1.5°F with a mean duration of 4.4±2.8 days significantly (p 0.0001) decreased to 99.7±1.8°F on the administration of Nimesulide. The liver and the renal profiles were found to be normal on records, and the side effects such as nausea and dyspepsia were reported only in 2% of patients. Nimesulide was found to be well-tolerated and effective as an antipyretic for acute fever management in adults during short-term use in real-world clinical practice.

Sections du résumé

BACKGROUND BACKGROUND
Various clinical trials have established anti-inflammatory and antipyretic properties of Nimesulide in a controlled setting, however, the fever management in real-world settings is quite different.
OBJECTIVE OBJECTIVE
To assess the effectiveness of Nimesulide in acute fever management in real-world clinical practice.
METHODOLOGY METHODS
A retrospective, multicenter study was conducted on electronic medical records (EMR) of 302 patients visiting out-patient departments at three centers between Jan 2016 and Jan 2020 and were prescribed Nimesulide for acute fever. The effectiveness of Nimesulide was analyzed as a change in fever from baseline to follow-up visit within 14 days and tolerability as the number of side effects captured post-Nimesulide ingestion.
RESULTS RESULTS
The provisional diagnosis at the baseline visit reported major complaints like fever, fever with abdominal pain, body-ache, cough and myalgia. The mean baseline body temperature was 103.2±1.5°F with a mean duration of 4.4±2.8 days significantly (p 0.0001) decreased to 99.7±1.8°F on the administration of Nimesulide. The liver and the renal profiles were found to be normal on records, and the side effects such as nausea and dyspepsia were reported only in 2% of patients.
CONCLUSION CONCLUSIONS
Nimesulide was found to be well-tolerated and effective as an antipyretic for acute fever management in adults during short-term use in real-world clinical practice.

Identifiants

pubmed: 34431273

Substances chimiques

Anti-Inflammatory Agents, Non-Steroidal 0
Sulfonamides 0
nimesulide V4TKW1454M

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

11-12

Informations de copyright

© Journal of the Association of Physicians of India 2011.

Auteurs

S Arulrhaj (S)

Senior Consultant, Sundaram Arulrhaj Hospitals, Thoothukudi, Tamil Nadu.

Mangesh Tiwaskar (M)

Senior Consultant, Shilpa Medical Research Centre, Mumbai, Maharashtra.

Mudit Sabharwal (M)

Senior Consultant, Dharma Clinic, GK1, New Delhi.

Rajiv Saikia (R)

Senior Consultant, St. Augustine Hospital Bongaigaon, Assam.

Sarfaraz Majid (S)

Senior Consultant, Ayub Ansari Nursing Home, Kolkata, West Bengal.

Rahul Rathod (R)

Cluster Head Medical Affairs, Medical Affairs, Dr Reddys Laboratories.

Amey Mane (A)

Head - Ideation and Clinical Research, Medical Affairs, Medical Affairs,Dr Reddys Laboratories.

Anup Petare (A)

Medical Advisor, Medical Affairs, Dr Reddys Laboratories.

Ravindra Kale (R)

Clinical Research Specialist, Dr Reddys Laboratories.

K K Aggarwal (KK)

Senior Consultant, Medicine and Cardiology, Dr. Aggarwal's clinic, New Delhi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH